Saturday 17 October 2026
Export SIGA’s income statement to Excel — free account
Siga Technologies Inc.
SIGA Healthcare Drug Manufacturers Specialty & Generic
Siga Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $94.6 million, down 31.8% from fiscal 2024. In the quarter to June 2026, revenue fell 49.5%, EPS fell 66.0% and free cash flow fell 76.0%, each against the same quarter a year earlier. Dividend growth for five consecutive years.
3.17
0.02
−0.63%
Follow SIGA
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 7 | 7 | 6 | 8 | 2 | 6 | 1 | 1 |
P/E ratio |
18.28 | 7.33 | 6.10 | 15.12 | 8.07 | 10.10 | 0.00 | 1.50 | 0.00 | 0.00 |
Altman Z-Score |
14.28 | 11.40 | 6.46 | 14.79 | 11.06 | 20.13 | 2.06 | 11.73 | (4.80) | (4.22) |
P/S ratio |
4.62 | 3.09 | 2.97 | 4.63 | 4.24 | 4.61 | 14.45 | 1.32 | 30.86 | 11.18 |
Altman Z″-Score (non-manufacturers) |
16.02 | 15.08 | 10.07 | 13.11 | 11.98 | 14.35 | 1.84 | 14.49 | (12.32) | (9.59) |
P/FCF ratio |
10.14 | 8.79 | 4.38 | 12.34 | 49.50 | 8.06 | 0.00 | 9.19 | 0.00 | 0.00 |
P/Operating CF |
(25.92) | 7.60 | 5.26 | (63.25) | 35.18 | 12.54 | (27.10) | (175.82) | (46.43) | (6.47) |
Beneish M-Score |
(4.02) | (2.12) | (3.36) | (2.82) | 18.96 | (0.28) | 27.61 | 38.80 | (3.48) | (3.04) |
Dividend Safety Score |
36 | — | — | — | — | — | — | — | — | — |
P/B ratio |
2.20 | 1.98 | 2.11 | 3.01 | 3.25 | 4.44 | 3.95 | 6.14 | 0.00 | 0.00 |
Price to Tangible BV |
2.21 | 1.99 | 2.12 | 3.03 | 3.27 | 4.47 | 3.99 | 6.19 | 0.00 | 0.00 |
EV/Sales |
4.66 | 3.11 | 3.03 | 5.17 | 4.66 | 4.94 | 14.38 | 1.25 | 34.32 | 13.16 |
EV/EBITDA |
18.18 | 6.12 | 5.04 | 13.26 | 6.94 | 7.26 | 0.00 | 1.68 | 0.00 | 0.00 |
EV/Operating CF |
10.15 | 8.86 | 4.47 | 13.77 | 54.13 | 8.63 | (21.12) | 8.67 | (22.90) | (1.69) |
EV/FCF |
10.23 | 8.86 | 4.48 | 13.78 | 54.37 | 8.63 | (21.09) | 8.68 | (22.76) | (1.69) |
Quick Ratio |
8.79 | 6.97 | 3.16 | 6.70 | 6.13 | 11.56 | 1.80 | 10.06 | 4.75 | 5.91 |
Current Ratio |
11.83 | 9.12 | 4.42 | 8.63 | 6.85 | 13.70 | 1.96 | 10.70 | 5.49 | 9.74 |
Net Debt/EBITDA |
(6.39) | (2.20) | (1.78) | (2.29) | (1.15) | (1.39) | 45.09 | (0.10) | (2.16) | (0.90) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 40.31% | 37.13% | 49.11% | 41.34% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.82 | 0.73 | (0.22) | (0.23) |
Asset Turnover |
0.41 | 0.56 | 0.62 | 0.54 | 0.73 | 0.72 | 0.13 | 2.74 | 0.08 | 0.09 |
Operating CF/Net income |
1.87 | 0.82 | 1.39 | 1.23 | 0.17 | 1.27 | 2.51 | 0.16 | 0.51 | 2.94 |
Capex/Depreciation |
(0.63) | (0.08) | (0.04) | 0.00 | (0.10) | (0.03) | (0.06) | (1.47) | (0.76) | (0.14) |
Interest Coverage |
— | — | — | 41.38 | 880.36 | 28.01 | (0.15) | 22.94 | (1.28) | (12.95) |
| 11.23% | 28.70% | 37.09% | 19.68% | 45.68% | 49.51% | (7.22%) | (383.07%) | 11.87% | 13.88% | |
| 10.04% | 23.75% | 30.29% | 16.55% | 38.10% | 32.34% | (3.60%) | 242.34% | (23.71%) | (22.90%) | |
ROIC |
33.78% | 72.41% | 111.88% | 37.39% | 78.23% | 443.69% | (8.62%) | 334.46% | 0.00% | 0.00% |
Return on Tangible Assets |
11.88% | 28.60% | 36.56% | 20.41% | 38.45% | 41.66% | (7.96%) | 383.03% | (118.06%) | (63.66%) |
Average Days of Receivables |
12.60 | 55.69 | 55.12 | 149.61 | 228.42 | 9.76 | 56.89 | 1.50 | 53.61 | 76.82 |
Research and Development Expense of Revenue |
21.10% | 8.87% | 11.74% | 20.33% | 7.44% | 8.75% | 49.75% | 2.73% | 135.95% | 131.51% |
Selling, General and Administrative Expense of Revenue |
22.43% | 18.12% | 15.75% | 31.70% | 13.49% | 11.78% | 49.56% | 2.70% | 100.28% | 91.50% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 |
Share Based Compensation of Revenue |
3.89% | 2.62% | 1.47% | 1.61% | 0.95% | 1.08% | 7.91% | 0.48% | 8.97% | 5.17% |
Graham Net Nets |
0.44 | 0.47 | 0.44 | 0.31 | 0.30 | 0.21 | 0.21 | 0.03 | (1.14) | (2.26) |
Graham Number |
4.57 | 7.48 | 7.70 | 4.94 | 6.97 | 5.15 | 0.00 | 12.33 | 6.55 | 8.83 |
Earnings Yield |
5.47% | 13.64% | 16.40% | 6.62% | 12.40% | 9.90% | (1.99%) | 66.46% | (9.69%) | (23.55%) |
Free Cash Flow Yield |
9.87% | 11.38% | 22.81% | 8.11% | 2.02% | 12.41% | (4.72%) | 10.88% | (4.89%) | (69.73%) |
Revenue per Share |
1.32 | 1.95 | 1.96 | 1.52 | 1.77 | 1.58 | 0.33 | 5.97 | 0.16 | 0.26 |
Operating CF per Share |
0.61 | 0.68 | 1.33 | 0.57 | 0.15 | 0.90 | (0.22) | 0.86 | (0.23) | (2.04) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
0.60 | 0.68 | 1.33 | 0.57 | 0.15 | 0.90 | (0.22) | 0.86 | (0.23) | (2.04) |
Cash per Share |
2.17 | 2.18 | 2.10 | 1.35 | 1.37 | 1.49 | 1.99 | 1.40 | 0.39 | 0.68 |
Shareholders Equity per Share |
2.78 | 3.03 | 2.76 | 2.33 | 2.31 | 1.64 | 1.21 | 1.29 | (4.10) | (5.03) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.78 | 3.03 | 2.76 | 2.33 | 2.31 | 1.64 | 1.21 | 1.29 | (4.10) | (5.03) |
Free Cash Flow |
43.12 | 48.72 | 94.78 | 41.61 | 11.44 | 71.50 | (18.23) | 68.77 | (18.49) | (116.84) |
Working Capital |
194.86 | 205.71 | 184.87 | 164.27 | 178.27 | 133.12 | 88.31 | 109.95 | 30.55 | 62.06 |
Capital Expenditures |
(0.35) | (0.04) | (0.02) | — | (0.05) | (0.02) | (0.03) | (0.10) | (0.10) | (0.02) |
Net Current Asset Value |
192.21 | 202.51 | 181.50 | 160.91 | 168.34 | 123.57 | 79.26 | 20.76 | (430.44) | (379.24) |
EV/EBIT |
18.61 | 6.17 | 5.07 | 13.42 | 6.98 | 7.31 | 0.00 | 1.68 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
Price to Operating Income |
18.44 | 6.12 | 4.97 | 12.01 | 6.36 | 6.82 | 0.00 | 1.78 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.52 | 0.41 | 0.40 | 0.28 | 0.22 | 0.25 | 0.20 | 0.41 | 0.95 | 0.58 |
Cash ROIC |
12.19% | 13.12% | 27.31% | 15.47% | 4.12% | 28.87% | (5.38%) | 23.67% | 8.35% | 64.19% |
Accounts Receivable Turnover |
7.74 | 6.56 | 4.21 | 1.72 | 3.07 | 33.29 | 8.73 | 253.67 | 4.95 | 4.39 |
Accounts Payable Turnover |
27.44 | 22.38 | 7.41 | 3.88 | 10.04 | 6.83 | 0.75 | 63.15 | 0.00 | 0.00 |
Inventory Turnover |
0.60 | 0.55 | 0.34 | 0.35 | 0.83 | 0.99 | 0.28 | 32.34 | 0.00 | 0.00 |
Average Days of Payables |
10.13 | 15.64 | 29.82 | 117.39 | 44.59 | 31.53 | 625.26 | 6.47 | 0.00 | 0.00 |
Days of Inventory on Hand |
602.78 | 578.18 | 1,314.98 | 1,374.03 | 428.94 | 499.88 | 1,976.28 | 11.14 | 0.00 | 0.00 |
Average Receivables |
12.21 | 21.15 | 33.27 | 64.53 | 43.50 | 3.75 | 3.06 | 1.88 | 2.48 | 3.42 |
Average Payables |
1.08 | 1.40 | 2.41 | 2.69 | 1.65 | 2.17 | 2.37 | 1.51 | 1.92 | 3.23 |
Average Inventory |
49.31 | 56.89 | 51.75 | 29.39 | 19.89 | 14.96 | 6.28 | 2.95 | 14.60 | 19.33 |
Average Assets |
231.90 | 249.34 | 224.69 | 204.88 | 182.28 | 174.20 | 201.00 | 174.06 | 152.83 | 173.36 |
Average Common Equity |
207.31 | 206.33 | 183.51 | 172.24 | 152.05 | 113.79 | 100.35 | (110.11) | (305.28) | (285.92) |
Columns are period end dates